Researchers developed an mRNA delivery system designed to improve embryo implantation. This approach could enhance ART outcomes and address uterine-factor infertility, with pre-clinical studies ...

The female trailblazers behind Operation Period explain how space discovery can be used to support the next generation of ...

Key considerations for health plan sponsors in covering family-building benefits (including in vitro fertilization (IVF)) ...

A 2013 review in the Journal of Applied Physiology states that hormonal therapies, where postmenopausal women take additional ...

KOMZIFTI™ (ziftomenib) launch generating early revenue momentum and rapid payer coverage decisions – – Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, su ...

Many couples nowadays think more than twice before deciding if they want to have kids. As a society, we're more aware of how ...

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...

Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for ...

Trump passed a law a year ago making it legal for U.S. corps to bribe world governments (its true), while the rest of the world is strengthening trade agreements through the rules of law that divert ...